Rock Springs Capital Management LP Q2 2020 Filing
Filed August 14, 2020
Portfolio Value
$3.6B
Holdings
143
Report Date
Q2 2020
Filing Type
13F-HR
All Holdings (143 positions)
| Stock | Value |
|---|---|
NBIXNEUROCRINE BIOSCIENCES INC | $166.7M |
UNHUNITEDHEALTH GROUP INC | $119.5M |
CNCCENTENE CORP DEL | $83.6M |
IRTCIRHYTHM TECHNOLOGIES INC | $75.4M |
2L9BLUEPRINT MEDICINES CORP | $74.9M |
HUMHUMANA INC | $74.1M |
ISRGINTUITIVE SURGICAL INC | $68.4M |
ZLABZAI LAB LTD | $66.8M |
ARGXARGENX SE | $64.8M |
AGIOAGIOS PHARMACEUTICALS INC | $63.1M |
—IMMUNOMEDICS INC | $59.5M |
PODDINSULET CORP | $56.9M |
BAXBAXTER INTL INC | $55.5M |
SRPTSAREPTA THERAPEUTICS INC | $55.4M |
HCAHCA HEALTHCARE INC | $53.3M |
EHCENCOMPASS HEALTH CORP | $51.6M |
ACADACADIA PHARMACEUTICALS INC | $51.1M |
ALNYALNYLAM PHARMACEUTICALS INC | $51.1M |
RAREULTRAGENYX PHARMACEUTICAL IN | $50.6M |
PCRXPACIRA BIOSCIENCES | $48.5M |
BIIBBIOGEN INC | $48.2M |
BMRNBIOMARIN PHARMACEUTICAL INC | $47.8M |
NVV1NOVAVAX INC | $47.6M |
TFXTELEFLEX INCORPORATED | $47.3M |
NVROEURNEVRO CORP | $46.1M |
NVTA1EURINVITAE CORP | $45.8M |
—MERSANA THERAPEUTICS INC | $44.0M |
SGENEURSEATTLE GENETICS INC | $42.5M |
—PORTOLA PHARMACEUTICALS INC | $41.5M |
IDXXIDEXX LABS INC | $41.3M |
ONCBEIGENE LTD | $40.5M |
EWEDWARDS LIFESCIENCES CORP | $40.2M |
FRPTFRESHPET INC | $39.8M |
MRTXEURMIRATI THERAPEUTICS INC | $39.8M |
AFWALIGN TECHNOLOGY INC | $39.2M |
BSXBOSTON SCIENTIFIC CORP | $38.6M |
PENPENUMBRA INC | $37.0M |
EXASEXACT SCIENCES CORP | $36.9M |
VRTXVERTEX PHARMACEUTICALS INC | $36.3M |
CHRSCOHERUS BIOSCIENCES INC | $36.2M |
APLTAPPLIED THERAPEUTICS INC | $35.8M |
ASMBASSEMBLY BIOSCIENCES INC | $35.0M |
ARDXARDELYX INC | $34.7M |
GLPGGALAPAGOS NV | $34.5M |
—EPIZYME INC | $33.8M |
AMRNAMARIN CORP PLC | $32.2M |
ASNDASCENDIS PHARMA A S | $31.6M |
CICIGNA CORP NEW | $30.2M |
AMGNAMGEN INC | $29.7M |
MDGLMADRIGAL PHARMACEUTICALS INC | $28.8M |
ADPTADAPTIVE BIOTECHNOLOGIES COR | $27.8M |
INCYINCYTE CORP | $26.0M |
MIRMMIRUM PHARMACEUTICALS INC | $25.7M |
RPRXROYALTY PHARMA PLC | $24.3M |
INSPINSPIRE MED SYS INC | $23.1M |
KRTXKARUNA THERAPEUTICS INC | $22.7M |
ACHCACADIA HEALTHCARE COMPANY IN | $22.6M |
—RETROPHIN INC | $20.9M |
ALXNALEXION PHARMACEUTICALS INC | $20.6M |
COLLCOLLEGIUM PHARMACEUTICAL INC | $20.6M |
APREAPREA THERAPEUTICS INC | $20.1M |
ADAPYADAPTIMMUNE THERAPEUTICS PLC | $19.9M |
CYTK 4 11/15/26CYTOKINETICS INC | $19.1M |
ALLOALLOGENE THERAPEUTICS INC | $18.9M |
HQYHEALTHEQUITY INC | $18.8M |
—ODONATE THERAPEUTICS INC | $18.5M |
PHRPHREESIA INC | $18.4M |
QUREUNIQURE NV | $18.3M |
GBTUSDGLOBAL BLOOD THERAPEUTICS IN | $18.2M |
TBPHTHERAVANCE BIOPHARMA INC | $17.4M |
ALLKGUSDALLAKOS INC | $17.2M |
CGENCOMPUGEN LTD | $17.0M |
—MYOKARDIA INC | $16.7M |
—FUSION PHARMACEUTICALS INC | $16.4M |
ARVNARVINAS INC | $16.1M |
WSTWEST PHARMACEUTICAL SVSC INC | $16.1M |
GOSS 5 06/01/27GOSSAMER BIO INC | $15.7M |
—CONSTELLATION PHARMCETICLS I | $15.5M |
GHGUARDANT HEALTH INC | $15.4M |
AM6AMICUS THERAPEUTICS INC | $15.3M |
CVETUSDCOVETRUS INC | $15.0M |
—BIOHAVEN PHARMACTL HLDG CO L | $14.9M |
JNJJOHNSON & JOHNSON | $14.8M |
—GW PHARMACEUTICALS PLC | $14.7M |
DVAXDYNAVAX TECHNOLOGIES CORP | $14.7M |
AGLEUSDAEGLEA BIOTHERAPEUTICS INC | $14.7M |
—RADIUS HEALTH INC | $13.7M |
—MOMENTA PHARMACEUTICALS INC | $13.3M |
TGTXTG THERAPEUTICS INC | $13.3M |
—PPD INC | $13.1M |
CNMDCONMED CORP | $13.0M |
FGENEURFIBROGEN INC | $12.8M |
DCPHEURDECIPHERA PHARMACEUTICALS IN | $12.5M |
HCATHEALTH CATALYST INC | $12.4M |
—TRANSLATE BIO INC | $11.8M |
BFAMBRIGHT HORIZONS FAM SOL IN D | $11.5M |
RYTMRHYTHM PHARMACEUTICALS INC | $11.4M |
—ZOGENIX INC | $11.2M |
IMVTIMMUNOVANT INC | $11.0M |
RIGLUSDRIGEL PHARMACEUTICALS INC | $10.8M |
Page 1 of 2Next